Strike Pharma

Russia
Kholbon, Zabaykalskiy (Transbaikal) Kray, Russia, 756 51

Company profile

Strike Pharma company profile

Strike Pharma is using the company’s proprietary Adaptable Drug Affinity Conjugate (ADAC). The company employs an antibody-based technique based on the genetic profile of each patient's tumor that destroys tumor cells while leaving other normal cells alone in the body. The company offers patients a low-cost, effective medication while minimizing the danger of unwanted effects.

Business identity

Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Founded
2020-01-01, Year

Headquarters

Postal code
756 51
Country code
RU
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
2
Total equity funding
$6M
Last funding
Series Unknown / $4.8M / 2022-02-22
Last equity funding
Series Unknown / $4.8M
Investors
3
Lead investors
1
Articles
6

Founders and investors

Lead investors

EIR Ventures

Investors

Almi InvestEIR VenturesFlerie Invest